Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 766.15
-25.15 (-3.18%)
At close: Jun 22, 2026
Anthem Biosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Anthem Biosciences stock has a consensus rating of "Strong Buy" and an average price target of ₹879.43. The average 1-year stock price forecast is 14.79% higher than the current stock price, while the lowest is ₹830.00 (+8.33%) and the highest is ₹956.00 (+24.78%).
Price Target: ₹879.43 (+14.79%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Anthem Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 2 | 2 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 7 | 7 | 7 |
Financial Forecast
Revenue This Year
25.72B
from 21.24B
Increased by 21.06%
Revenue Next Year
30.97B
from 25.72B
Increased by 20.44%
EPS This Year
12.93
from 10.74
Increased by 20.37%
EPS Next Year
15.67
from 12.93
Increased by 21.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 26.6B | ||
| Avg | 25.7B | ||
| Low | 25.3B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 25.0% | ||
| Avg | 21.1% | ||
| Low | 19.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 12.93 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 20.4% | ||
| Low | - |